Citius Pharmaceuticals Inc.

NASDAQ: CTXR
Share price (1/8/25): $3.71
Market cap (1/8/25): $28.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 425 93 pages Agreement and Plan of Merger and Reorganization by and Among Citius Pharmaceuticals, Inc., Citius Oncology, Inc., Tenx Keane Acquisition and Tenx Merger Sub, Inc. Dated as of October 23, 2023

from 8-K 93 pages Agreement and Plan of Merger and Reorganization by and Among Citius Pharmaceuticals, Inc., Citius Oncology, Inc., Tenx Keane Acquisition and Tenx Merger Sub, Inc. Dated as of October 23, 2023

from 8-K 57 pages Agreement and Plan of Merger by and Among Citius Pharmaceuticals, Inc., Citius Lmb Acqusition Corp. and Leonard-Meron Biosciences, Inc. Dated as of March 30, 2016 1 Agreement of Plan and Merger

from 8-K 22 pages Introduction